Past studies
Adults
| Sponsor | Study | Target population | Status |
| Sanofi | Tdap vaccine | Young adults | Completed |
| Merck | Cytomegalovirus vaccine | Young women | Completed |
| Medicago | Flu vaccine for elderly: dose comparison | 2 groups: 18-49 years of age ≥ 65 years of age | Completed |
| Medicago | Flu vaccine for adults | Healthy adults | Completed |
| VBI | Hepatitis B vaccine | Adults in stable health | Completed |
| Investigator initiated | Flu vaccine | Adults with Rheumatoid arthritis | Completed |
Pediatrics
| Sponsor | Study | Target population | Status |
| CIRN network | Pneumococcal vaccines 1 vs 2 doses | Infants | Completed |
| CIRN network | Flu vaccine | Infants | Completed |
| Merck | Pneumococcal vaccine (Phase 3) | Infants | Completed |
| Merck | Pneumococcal vaccine (Phase 2) | Newborns | Completed |
| MedImmune | Monoclonal antibody against Respiratory Syncytial Virus (RSV) | Healthy preterm infants | Completed |
These are only the recent, completed, vaccine studies. We have successfully conducted over 100 studies”